We are live on ! Find out more
MLNT

Melinta Therapeutics, Inc. Common Stock
MLNT

Delisted

MLNT was delisted on the 10th of January, 2020.

Back to rankings

83 hedge funds and large institutions have $136M invested in Melinta Therapeutics, Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 28 increasing their positions, 18 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

56% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 18

54% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 13

6% more funds holding

Funds holding: 78 → 83 (+5)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

26% less capital invested

Capital invested by funds: $183M → $136M (-$47M)

73% less call options, than puts

Call options by funds: $256K | Put options by funds: $951K

Holders
83
Holders Change
+5
Holders Change %
+6.41%
% of All Funds
1.9%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
20
Increased
28
Reduced
18
Closed
13
Calls
$256K
Puts
$951K
Net Calls
-$695K
Net Calls Change
+$290K

Top Buyers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
+$41.1M
2
OH
Oikos Holdings
New York
+$26.3M
3
FTIOP
Fiduciary Trust International of Pennsylvania
Pennsylvania
+$3.94M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$3.94M
5
Wellington Management Group
Wellington Management Group
Massachusetts
+$3.87M

Top Sellers

Rank Fund Capital Flow
1
TCIM
TIAA CREF Investment Management
New York
-$696K
2
ARTA
A.R.T. Advisors
New York
-$525K
3
BCM
Bridgeway Capital Management
Texas
-$512K
4
BG
Bellevue Group
Switzerland
-$507K
5
Deutsche Bank
Deutsche Bank
Germany
-$405K
Name Holding Trade Value Shares
Change 		Change in
Stake
BCM
26
Bridgeway Capital Management
Texas
$290K -$512K -7,780 -50%
Bank of America
27
Bank of America
North Carolina
$266K -$39K -593 -8%
GF
28
Gabelli Funds
New York
$210K -$131K -2,000 -26%
Wolverine Trading
29
Wolverine Trading
Illinois
$193K +$342K +5,204 New
TCIM
30
TIAA CREF Investment Management
New York
$178K -$696K -10,583 -69%
California State Teachers Retirement System (CalSTRS)
31
California State Teachers Retirement System (CalSTRS)
California
$170K +$98.9K +1,504 +48%
OAM
32
Oxford Asset Management
United Kingdom
$166K +$296K +4,496 New
EGM
33
Engineers Gate Manager
New York
$157K +$278K +4,231 New
Susquehanna International Group
34
Susquehanna International Group
Pennsylvania
$150K -$179K -2,727 -40%
AllianceBernstein
35
AllianceBernstein
Tennessee
$147K +$27.6K +420 +12%
ARTA
36
A.R.T. Advisors
New York
$142K -$525K -7,981 -67%
Goldman Sachs
37
Goldman Sachs
New York
$131K -$175K -2,655 -43%
TA
38
Teachers Advisors
New York
$128K – – –
Squarepoint
39
Squarepoint
New York
$127K +$225K +3,420 New
California Public Employees Retirement System
40
California Public Employees Retirement System
California
$115K – – –
TA
41
Teton Advisors
New York
$115K +$6.58K +100 +3%
HCM
42
Highbridge Capital Management
New York
$108K +$192K +2,924 New
Creative Planning
43
Creative Planning
Kansas
$98K +$175K +2,658 New
FSA
44
Franklin Street Advisors
North Carolina
$97K +$1.84K +28 +1%
Manulife (Manufacturers Life Insurance)
45
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$97K +$61.1K +929 +55%
RhumbLine Advisers
46
RhumbLine Advisers
Massachusetts
$93K +$31.4K +478 +23%
Citadel Advisors
47
Citadel Advisors
Florida
$88K -$90.3K -1,373 -37%
Barclays
48
Barclays
United Kingdom
$74K -$280K -4,260 -68%
PPA
49
Parametric Portfolio Associates
Washington
$74K -$7.76K -118 -6%
AIG
50
American International Group
New York
$72K +$42.3K +643 +50%
1
2
3 4

MLNT Hedge Fund Activity: Q1 2018 in Review

83 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Melinta Therapeutics, Inc. Common Stock (MLNT) for Q1 2018, worth a combined $136M — down 26% from $183M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new MLNT positions and 13 closed out — a net gain of 7 holders — while 28 added to existing stakes and 18 trimmed.

The largest buyer was Deerfield Management, opening a new position worth an estimated $41.1M. The largest seller was TIAA CREF Investment Management, cutting an estimated $696K.

  • 83 institutional investors held Melinta Therapeutics, Inc. Common Stock (MLNT) as of Q1 2018, up from 78 in Q4 2017.
  • Funds reported $136M of Melinta Therapeutics, Inc. Common Stock stock for Q1 2018, down 26% quarter-over-quarter.
  • 20 funds opened new Melinta Therapeutics, Inc. Common Stock positions in Q1 2018 and 13 closed out, a net change of +7 holders.
  • The largest Melinta Therapeutics, Inc. Common Stock buyer in Q1 2018 was Deerfield Management, an estimated $41.1M added.
  • The largest Melinta Therapeutics, Inc. Common Stock seller in Q1 2018 was TIAA CREF Investment Management, an estimated $696K sold.

Based on aggregated 13F filings for Q1 2018.